Compare Erasca Inc. Common Stock (ERAS) vs Constellation Brands Inc. Common Stock (STZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Erasca Inc. Common Stock vs Constellation Brands Inc. Common Stock — how do they compare? Erasca Inc. Common Stock trades at $14.6 (market cap $5.17B), while Constellation Brands Inc. Common Stock trades at $128.45 (market cap $21.50B). The key difference: Constellation Brands Inc. Common Stock is far larger — about 4.2× Erasca Inc. Common Stock's market cap, and Constellation Brands Inc. Common Stock pays a 3.24% dividend while Erasca Inc. Common Stock pays none. Which is the better fit depends on your goals.
| ERAS | STZ | |
|---|---|---|
Market Cap | $5.17B | $21.50B |
Volume | 5,313,379 | 2,104,680 |
Sector | Health | Consumer Staples |
52-Week High | $22.47 | $166.68 |
52-Week Low | $2.20 | $112.77 |
Typical Hold Time | 1 Days | — |
Enterprise Value | $4.95B | $31.72B |
Dividend Yield | — | 3.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ERAS trades at $14.78, down 4.4% today, with a bullish technical signal from moving averages and a consensus analyst price target of $22.50. The company is a clinical-stage oncology firm with no revenue, reporting a net loss of $124.55 million in 2025, but holds significant liquidity and has three potential registration-enabling trials ahead. Recent news highlights FDA Fast Track designation for its lead candidate ERAS-0015.
The outlook is speculative, driven by clinical trial progress; upside exists if trials succeed, but high cash burn and shareholder investigations pose substantial risks. Investment hinges on binary outcomes from drug development, making it suitable only for risk-tolerant investors focused on biotech.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Erasca Inc. Common Stock
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →About Constellation Brands Inc. Common Stock
Constellation Brands, Inc. is a US producer and marketer of beer, wine, and spirits, known for importing Mexican beer brands Corona and Modelo alongside a portfolio of wine and craft spirits labels.
Read more on STZ →
